drugset / Trial / NCT03364725

Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study

NCT03364725

Phase 4 Unknown 30 enrolled Id Care AbbVie · collab
NaSingle-groupOpen-labelTreatment

Summary

To demonstrate that colocation treatment of substance use disorder and Hepatitis C infection concurrently while proving addiction counselling will achieve increased duration of sobriety and elimination of Hepatitis C virus in study participants.

Timeline

Start
2018-01-15
Primary completion
2018-09-01
Completion
2019-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject glecaprevir Other / unclassified